object
determin
frequenc
respiratori
pathogen
infant
diagnos
acut
lower
respiratori
tract
infect
method
prospect
crosssect
observ
studi
conduct
infant
hospit
diagnosi
acut
lower
respiratori
tract
infect
alrti
tertiari
care
hospit
metropolitan
citi
western
india
nasopharyng
swab
analyz
multiplex
real
time
polymeras
chain
reaction
virus
bacteria
h
influenza
type
b
c
pneumonia
pneumonia
entir
data
enter
microsoft
excel
sheet
frequenc
determin
result
one
hundr
elig
infant
enrol
pathogen
detect
sampl
includ
respiratori
syncyti
virus
rsv
b
human
rhinoviru
adenoviru
human
parainfluenza
virus
human
bocaviru
human
metapneumoviru
b
influenza
pdm
parechoviru
human
coronavirus
haemophilu
influenza
type
b
chlamydia
pneumonia
mycoplasma
pneumonia
influenza
influenza
b
human
coronaviru
enteroviru
detect
rate
coinfect
rhinoviru
common
multipl
pathogen
conclus
spectrum
viral
etiolog
alrti
highlight
etiolog
diagnosi
alrti
would
enabl
specif
antivir
therapi
restrict
antibiot
use
help
know
burden
diseas
acut
lower
respiratori
tract
infect
alrti
lead
caus
morbid
mortal
worldwid
especi
first
year
life
respons
death
neonat
death
children
age
mo
death
children
age
consid
respons
death
children
age
group
southeast
asia
respiratori
infect
caus
varieti
virus
bacteria
respiratori
virus
commonest
etiolog
agent
alrti
among
infant
pauciti
data
regard
etiolog
agent
alrti
among
infant
western
part
india
data
provid
studi
carri
differ
part
india
may
lacuna
use
test
less
sensit
nonspecif
unabl
detect
wide
rang
pathogen
simultan
data
import
ensur
unnecessari
prescript
antibacteri
agent
minim
appropri
measur
taken
limit
possibl
spread
nosocomi
infect
advent
diagnost
molecular
method
multiplex
realtim
polymeras
chain
reaction
provid
rare
opportun
identifi
virus
respons
respiratori
infect
method
sensit
accur
effici
tradit
method
base
isol
antibodydetect
serolog
capabl
identifi
multipl
pathogen
prospect
crosssect
observ
studi
carri
tertiari
care
universityaffili
hospit
metropolitan
citi
western
india
obtain
approv
institut
ethic
committe
infant
age
mo
either
gender
alrti
enrol
studi
obtain
written
inform
consent
parent
guardian
purpos
studi
alrti
defin
presenc
cough
fever
temperatur
wk
tachypnea
breath
breath
min
wheez
stridor
calm
cyanosi
subcost
retract
apnea
detail
histori
obtain
parent
guardian
regard
variou
risk
factor
defin
manner
given
tabl
purpos
studi
differenti
diagnosi
provid
clinician
note
inform
enter
case
record
form
clinic
diagnosi
record
base
clinician
perspect
judgement
turn
made
basi
inform
data
obtain
histori
clinic
examin
find
result
laboratori
radiolog
investig
nasopharyng
secret
collect
use
flock
swab
puritan
unitranz
rt
transport
system
contain
swab
univers
transport
medium
puritan
medic
product
usa
follow
standard
procedur
sampl
immedi
transport
molecular
diagnost
laboratori
maintain
cold
chain
store
use
total
nucleic
acid
manual
extract
use
pathogen
kit
stratec
molecular
gmbh
berlin
germani
simultan
isol
bacteri
viral
dna
plu
viral
rna
nucleic
acid
extract
univers
transport
medium
contain
nasopharyng
swab
np
elut
final
volum
accord
rtp
pathogen
protocol
intern
rna
viru
control
brome
mosaic
viru
fasttrack
diagnost
luxembourg
introduc
lysi
buffer
sampl
monitor
nucleic
acid
extract
revers
transcript
amplif
perform
abi
realtim
pcr
system
thermocycl
appli
biosystem
usa
use
follow
cycl
condit
min
min
cycl
fluoresc
read
taken
step
cycl
threshold
cycl
ct
valu
determin
manual
adjust
sampl
amplifi
six
parallel
reaction
contain
primer
probe
four
differ
target
detect
virus
bacteria
addit
intern
control
reaction
posit
neg
viru
plasmid
control
provid
kit
includ
run
monitor
assay
perform
followup
contact
infant
kept
post
collect
nasopharyng
swab
low
birth
weight
birth
weight
less
kg
determin
record
histori
malnourish
actual
weight
less
weightforag
chart
provid
respect
gender
food
drink
breastmilk
offer
infant
within
first
mo
life
exposur
smoke
exposur
cigarett
smoke
smoke
stove
chullah
congenit
heart
diseas
detect
clinic
featur
suggest
congenit
heart
diseas
confirm
relev
investig
includ
ecg
radiographi
twodimension
echocardiographi
data
enter
microsoft
excel
sheet
frequenc
etiolog
agent
determin
one
hundr
infant
male
infant
f
median
age
mo
iqr
alrti
admit
hospit
studi
period
juli
decemb
enrol
studi
fiftytwo
diagnos
bronchiol
diagnos
bronchopneumonia
pneumonia
radiograph
pulmonari
infiltr
consolid
hyperlusc
shown
tabl
enrol
children
cough
fever
breathless
vari
durat
eleven
children
congenit
heart
diseas
born
prematur
low
birthweight
sixtyon
infant
breastf
histori
exposur
smoke
environ
shown
tabl
sampl
posit
least
one
pathogen
posit
sampl
common
pathogen
detect
respiratori
syncyti
viru
rsv
hrv
adenovirus
adv
influenza
influenza
b
human
coronaviru
hcov
enteroviru
ev
detect
pneumonia
c
pneumonia
h
influenza
type
b
three
bacteria
detect
shown
tabl
posit
multipl
pathogen
posit
singl
pathogen
among
singl
detect
rsv
common
viru
detect
hrv
common
viru
detect
among
multipl
detect
hcov
nl
hcov
piv
pev
pneumonia
h
influenza
type
b
detect
codetect
andnev
singl
pathogen
c
pneumonia
detect
singl
pathogen
codetect
involv
three
pathogen
tabl
three
infant
age
mo
lrti
sever
bronchopneumonia
succumb
develop
progress
worsen
clinic
condit
two
infant
evid
congenit
heart
diseas
infant
without
congenit
heart
diseas
succumb
ill
sever
risk
factor
prematur
birth
low
birth
weight
malnutrit
absenc
exclus
breast
feed
burden
viral
lrti
among
infant
western
india
poorli
understood
due
pauciti
publish
report
commun
use
latest
technolog
advanc
identif
viral
agent
aim
fill
gap
knowledg
studi
shown
sampl
infant
symptom
respiratori
infect
posit
viral
agent
identif
rsv
hrv
adv
hbov
hmpv
predomin
virus
identifi
rsv
ab
detect
studi
sampl
figur
well
within
proport
report
earlier
studi
suggest
matern
antibodi
ineffect
prevent
rsv
infect
infanc
lead
substanti
morbid
hrv
second
common
viru
detect
preval
infant
within
rang
report
investig
earlier
consid
common
caus
upper
respiratori
tract
infect
urti
less
commonli
less
caus
lrti
hrv
establish
role
also
common
caus
lrti
among
infant
adv
account
virusdetectionposit
sampl
infant
describ
one
major
caus
lrti
children
age
adult
infant
present
studi
find
seem
suggest
rethink
view
could
order
human
bocaviru
found
infant
posit
sampl
viru
frequent
identifi
infant
although
role
diseas
pathogenesi
yet
clear
longtin
et
al
document
preval
rate
higher
children
age
decreas
age
impli
protect
due
antibodi
hbov
acquir
earli
life
present
studi
also
detect
novel
influenza
pdm
viru
infant
influenza
novel
pdm
detect
perhap
endem
influenza
viru
replac
suppress
circul
novel
pdm
viru
result
outbreak
report
start
earli
preval
h
influenza
type
b
hib
develop
countri
decreas
due
administr
hib
contain
pentaval
vaccin
pentaval
vaccin
includ
part
univers
immun
program
sever
indian
state
tamil
nadu
kerala
gujarat
haryana
karnataka
goa
jammu
kashmir
puducherri
implement
maharashtra
period
studi
explain
detect
hib
present
studi
earlier
studi
mention
coinfect
rate
studi
multipl
pathogen
note
posit
sampl
hrv
includ
three
patient
isol
three
organ
hrv
adv
hrv
hmpv
adv
hrv
hmpv
pev
adv
adenovirus
hmpv
human
metapneumoviru
hrv
human
rhinoviru
pev
parechoviru
piv
parainfluenza
viru
commonest
viru
detect
multipl
detect
coinfect
increasingli
report
infant
clinic
signific
coinfect
fulli
elucid
author
rule
possibl
high
sensit
multiplex
pcr
may
led
detect
residu
nucleic
acid
prior
viral
infect
virus
like
adv
hbov
lymphoid
tissu
known
serv
reservoir
may
lead
prolong
shed
asymptomat
individu
caus
transmiss
virus
suscept
individu
wellknown
virus
like
hrv
hbov
continu
shed
long
time
onset
symptom
addit
durat
shed
virus
may
depend
whether
sole
pathogen
accompani
copathogen
surpris
hrv
adv
hcov
hbov
frequent
detect
coinfect
present
studi
hbovoccur
frequent
virus
still
uncertain
whether
hbov
pathogen
concomit
bystand
viru
similarli
due
nasal
carriag
pathogen
bacteria
like
pneumonia
hib
result
nasopharyng
swab
may
mislead
howev
hrv
neglect
persist
sinc
shown
associ
worsen
outcom
could
attribut
abil
reduc
capac
bronchial
epitheli
cell
prolifer
selfrepair
thu
posit
result
must
interpret
cautious
correl
patient
clinic
symptom
differ
posit
rate
abovement
studi
detect
virusesbacteria
present
studi
could
explain
variou
factor
like
differ
age
group
patient
differ
type
sampl
collect
differ
diagnost
method
use
also
wide
interregion
variat
differ
climat
issu
associ
presenc
risk
factor
multipl
pathogen
mortal
could
determin
due
small
sampl
avail
could
object
futur
research
use
sensit
novel
method
detect
viral
agent
strength
studi
specimen
choic
detect
respiratori
virus
nasopharyng
aspir
npa
nasal
wash
disadvantag
unpleas
procedur
need
suction
devic
case
npa
attend
risk
aspir
gener
aerosol
collect
nasal
wash
henc
procedur
feasibl
widespread
use
clinic
practic
contrast
collect
nasopharyng
swab
easi
painless
perform
anywher
requir
addit
devic
also
newli
develop
flock
swab
use
studi
sensit
less
traumat
pediatr
patient
also
accept
parent
absenc
singl
test
detect
etiolog
agent
greatest
hurdl
determin
etiolog
agent
case
lrti
multiplex
pcr
overcom
hurdl
extent
potenti
reduc
overal
use
antibiot
improv
target
use
antibiot
turn
help
control
nosocomi
transmiss
virus
howev
kit
detect
organ
mention
therefor
may
miss
virus
bacteria
contribut
alrti
may
explain
neg
sampl
studi
high
concord
virus
identifi
use
multiplex
pcr
nasopharyng
aspir
identifi
studi
pulmonari
sampl
patient
acut
respiratori
infect
previous
publish
literatur
provid
confid
organ
identifi
studi
nasopharyng
aspir
respons
lower
respiratori
infect
case
control
studi
would
benefici
know
presenc
virus
bacteria
asymptomat
infant
could
area
futur
research
studi
establish
feasibl
use
multiplex
pcr
detect
viral
agent
nasopharyng
swab
also
provid
baselin
data
like
virus
detect
nasopharynx
infant
clinic
manifest
lrti
studi
larger
sampl
recruit
span
season
provid
greater
clariti
contribut
variou
etiolog
agent
